BO 1341

BO 1341 is a PBPs inhibitor and an antipseudomonal semisynthetic cephalosporin, which belongs to the class of Antibiotic. BO 1341 exhibits antibacterial activity against most Gram-negative bacteria, such as Pseudomonas aeruginosa (MIC90: 1.56 μg/mL), Pseudomonas maltophilia (MIC50: 1.56 μg/mL), and Acinetobacter calcoaceticus (MIC90: 3.13 μg/mL) . BO 1341 can be used in the research of infectious diseases[1].

Product Specifications

CAS Number

[119068-46-1]

UNSPSC

12352005

Target

Antibiotic; Bacterial

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Smiles

[O-]C(C1=C(C[N+]2=CC3=CC(O)=C(O)C=C3C=C2)CS[C@@]([C@@H]4NC(/C(C5=CSC(N)=N5)=N/OC(C)(C)C(O)=O)=O)([H])N1C4=O)=O

Molecular Formula

C26H24N6O9S2

Molecular Weight

628.63

References & Citations

[1]Nakagawa S, et al. In vitro and in vivo antibacterial activities of BO-1341, a new antipseudomonal cephalosporin. Antimicrob Agents Chemother. 1989 Sep;33 (9) :1423-7.